Veterinary Medicines

Neopen 200000 IU/ml - 100 mg/ml Suspensie voor injectie

Authorised
  • NEOMYCIN SULFATE
  • Benzylpenicillin procaine
Download as PDF

Product identification

Medicine name:
Neopen 200000 IU/ml - 100 mg/ml Suspensie voor injectie
Neopen 200000 IU/ml - 100 mg/ml Suspension injectable
Neopen 200000 IU/ml - 100 mg/ml Injektionssuspension
Active substance:
  • NEOMYCIN SULFATE
  • Benzylpenicillin procaine
Target species:
  • Sheep
  • Cat
  • Pig
  • Dog
  • Cattle
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • NEOMYCIN SULFATE
    144.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Benzylpenicillin procaine
    200000.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Sheep
      • Meat and offal
        56
        day
    • Cat
    • Pig
      • Meat and offal
        45
        day
    • Dog
    • Cattle
      • Meat and offal
        89
        day
      • Milk
        4
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        89
        day
      • Meat and offal
        4
        day
    • Dog
    • Cat
    • Sheep
      • Meat and offal
        56
        day
    • Pig
      • Meat and offal
        45
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Neopen 250 ml glass Bottle Suspension for injection
  • Neopen 100 ml glass Bottle Suspension for injection
  • Neopen 250 ml PET Bottle Suspension for injection
  • Neopen 100 ml PET Bottle Suspension for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Productions S.r.l.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 20/11/2023
Download
French (PDF)
Published on: 19/12/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 19/12/2023
Download
French (PDF)
Published on: 19/12/2023
Download
German (PDF)
Published on: 19/12/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 21/12/2023
Download
French (PDF)
Published on: 21/12/2023
Download
German (PDF)
Published on: 21/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."